Kerstin Dolph

Nanoscope Therapeutics Accelerates Sight-Restoring Drug Development with New Gene Therapy Manufacturing Partnership

by | Oct 18, 2022
Dallas-based Nanoscope Therapeutics is accelerating the development of therapies that could restore sight in patients with the help of a publicly traded firm. The retinal degenerative diseases-focused biotech company announced a new gene therapy manufacturing partnership with contract research organization Charles River Laboratories International.
MORE